Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 3,091 | 1,104 | 3,070 | 53 | 24 |
| Cost of Goods | 2,569 | 944 | 2,415 | 19 | 17 |
| Gross Profit | 522 | 159 | 655 | 34 | 8 |
| Operating Expenses | 854 | 1,138 | -4 | 149 | 74 |
| Operating Income | 237 | -34 | 1,074 | -96 | -50 |
| Other Income | -2 | -1 | -3 | 0 | 0 |
| Pre-tax Income | 235 | -35 | 1,071 | -96 | -50 |
| Income Tax | 1 | 1 | -1 | -1 | -28 |
| Net Income Continuous | 235 | -36 | 1,071 | -95 | -22 |
| Net Income | $235 | $-36 | $1,071 | $-95 | $-22 |
| EPS Basic Continuous Ops | 0.03 | 0.00 | 0.13 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.03 | 0.00 | 0.13 | -0.01 | 0.00 |
| EBITDA(a) | $251 | $-22 | $1,087 | $-74 | $-40 |